Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 32, 2024 - Issue 5
Submit an article Journal homepage
94
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Use of Intracameral Tissue Plasminogen Activator During Uveitic Cataract Surgery

Wen F. Hua Flaum Eye Institute, University of Rochester, Rochester, New York, USAView further author information
, MD, PhD,
Tyler Etheridgeb Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USAView further author information
, MD &
Marissa B. Larochelleb Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USACorrespondence[email protected]
View further author information
, MD
Pages 673-677 | Received 23 Oct 2022, Accepted 18 Mar 2023, Published online: 20 Apr 2023

References

  • Geanon JD, Tripathi BJ, Tripathi RC, Barlow GH. Tissue plasminogen activator in avascular tissues of the eye: a quantitative study of its activity in the cornea, lens, and aqueous and vitreous humors of dog, calf, and monkey. Exp Eye Res. 1987;44(1):55–63. doi:10.1016/s0014-4835(87)80025-8.
  • Tripathi RC, Park JK, Tripathi BJ, Millard CB. Tissue plasminogen activator in human aqueous humor and its possible therapeutic significance. Am J Ophthalmol. 1988;106(6):719–722. doi:10.1016/0002-9394(88)90707-6.
  • Yoshitomi F, Utsumi E, Hayashi M, Futenma M, Yamada R, Yamada S. Postoperative fluctuations of tissue plasminogen activator (t-PA) in aqueous humor of pseudophakes. J Cataract Refract Surg. 1991;17(5):543–546. doi:10.1016/s0886-3350(13)81039-5.
  • Dotan A, Kaiserman I, Kremer I, Ehrlich R, Bahar I. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome. Br J Ophthalmol. 2014;98(2):252–255. doi:10.1136/bjophthalmol-2013-304294.
  • Mehta JS, Adams GG. Recombinant tissue plasminogen activator following paediatric cataract surgery. Br J Ophthalmol. 2000;84(9):983–986. doi:10.1136/bjo.84.9.983.
  • Heiligenhaus A, Steinmetz B, Lapuente R, et al. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study. Br J Ophthalmol. 1998;82(7):810–815. doi:10.1136/bjo.82.7.810.
  • Jaffe GJ, Abrams GW, Williams GA, Han DP. Tissue plasminogen activator for postvitrectomy fibrin formation. Ophthalmology. 1990;97(2):184–189. doi:10.1016/s0161-6420(90)32618-0.
  • Siatiri H, Beheshtnezhad AH, Asghari H, Siatiri N, Moghimi S, Piri N. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery. Br J Ophthalmol. 2005;89(11):1458–1461. doi:10.1136/bjo.2005.071407.
  • Lerner LE, Patil AJ, Kenney MC, Minckler D. Use of intraocular human recombinant tissue plasminogen activator as an adjunct treatment of posterior synechiae in patients with uveitis. Retin Cases Brief Rep. 2012;6(3):290–293. doi:10.1097/icb.0b013e31822a2f4f.
  • Williams ER, Patnaik JL, Miller DC, et al. Iris manipulation during phacoemulsification: intraoperative and postoperative complications. Int J Ophthalmol–Chi. 2021;14(5):676–683. doi:10.18240/ijo.2021.05.06.
  • Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol. 2014;158(4):676–692.e7. doi:10.1016/j.ajo.2014.06.018.
  • Ozates S, Berker N, Ozdal PC, Erol YO. Phacoemulsification in patients with uveitis: long-term outcomes. BMC Ophthalmol. 2020;20(1): 109-8. doi:10.1186/s12886-020-01373-5.
  • Wedrich A, Menapace R, Ries E, Polzer I. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery. J Cataract Refract Surg. 1997;23(6):873–877. doi:10.1016/s0886-3350(97)80246-5.
  • Rehfeldt K, Höh H. Therapeutic and prophylactic application of TPA (recombinant tissue plasminogen activator) into the anterior chamber of the eye. Ophthalmologe. 1999;96(9):587–593. doi:10.1007/s003470050457.
  • Wedrich A, Menapace R, Mühlbauer-Ries E. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery. Int Ophthalmol. 1994;18(5):277–280. doi:10.1007/bf00917830.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.